RAM
ANGO icon

Riggs Asset Management’s AngioDynamics ANGO Stock Holding History

Riggs Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,000
Closed -$52K – 316
2021
Q3 		$52K Hold
2,000
– – 0.02% 152
2021
Q2 		$54K Buy
+2,000
New +$48.8K 0.02% 153

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Riggs Asset Management's ANGO Position: Q4 2021 in Review

Riggs Asset Management sold out of AngioDynamics (ANGO) in Q4 2021, closing a stake of 2,000 shares — an estimated $52K sold.

Riggs Asset Management first reported a position in ANGO in Q2 2021 and held it in 2 quarters. The position peaked at $54K in Q2 2021. 170 funds tracked by Wall St. Rank hold ANGO as of Q4 2021.

  • Riggs Asset Management reported no remaining AngioDynamics position as of Q4 2021 after selling out during the quarter.
  • Riggs Asset Management sold 2,000 AngioDynamics shares in Q4 2021, an estimated $52K.
  • Riggs Asset Management first reported a position in AngioDynamics in Q2 2021 and held it in 2 quarters.
  • Riggs Asset Management's AngioDynamics position peaked at $54K in Q2 2021.
  • 170 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2021.

Based on Riggs Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.